Figure 2: Maintenance Of Healing Rates Of Ee In Adults By Month (study 177) (Esomeprazole Fig1)
This description is not-available.*
Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 59651-561
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 59651-561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 3: Maintenance Of Ee Healing Rates In Adults By Month (study 178) (Esomeprazole Fig2)
This description seems to detail a study or data regarding the effectiveness or maintenance of Esomeprazole Magnesium at different dosage levels. The percentages shown likely indicate the success rate or effectiveness of the medication over a certain period of time. The text also seems to mention a placebo group for comparison. The study appears to span multiple months.*
Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)
This text provides information on a study that compared the efficacy of Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg doses with a Placebo in relation to patient symptom relief. The study appears to have recorded data up to 21 days, with the results showing the percentage of patients who were symptom-free at different points in time (7, 14, 21 days). This numerical data can help evaluate the effectiveness of these treatments in managing symptoms.*
Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)
This information seems to be about the results of a study or trial comparing the efficacy of Esomeprazole Magnesium Delayed-Release Capsules in 40 mg and 20 mg doses with a placebo in terms of alleviating symptoms in patients. According to the data provided, 100% of patients taking Esomeprazole Magnesium Delayed-Release Capsules at either dose were symptom-free, while the placebo had a lower effectiveness rate.*
Package Label-principal Display Panel (20 mg (30 Capsules Bottle))
This text contains information about NDC 59651-561-30, which is a medication called Esomeprazole Magnesium Delayed-Release Capsules USP. Each capsule contains esomeprazole magnesium trihydrate USP equivalent to 20 mg of esomeprazole. The usual adult dosage instructions can be found in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) and the container should be kept tightly closed. It is distributed by Aurobindo Pharma USA, Inc. and made in India.*
Package Label-principal Display Panel (20 mg (1 x 14) Unit-dose Capsules)
This text is a description of Esomeprazole Magnesium Delayed-Release Capsules USP, containing 20 mg of Esomeprazole magnesium. It gives information on the dosage, storage conditions, and the need for a child-resistant container. The text also provides details for the pharmacist regarding dispensing and mentions the manufacturer's address.*
Package Label-principal Display Panel (40 mg (30 Capsules Bottle))
This is a description for Esomeprazole Magnesium Delayed-Release Capsules USP by Aurobindo Pharma USA, Inc. Each capsule contains esomeprazole 40 mg. The usual adult dosage information can be found in the package insert. The medication guide should be dispensed separately to each patient. The capsules are stored at 20° to 25°C and the manufacturing details include the address of Aurobindo Pharma USA, Inc. in East Windsor, NJ.*
Package Label-principal Display Panel (40 mg (10 x 10) Unit-dose Capsules)
This is a description of a pharmaceutical product. It is a package of Esomeprazole Magnesium Delayed-Release Capsules USP, containing 100 unit-dose capsules. Each capsule contains Esomeprazole magnesium trinydrate USP equivalent to esomeprazole 40 mg. The recommended adult dosage should be consulted from the package insert. The storage conditions are specified to maintain efficacy. The text also mentions the importance of keeping the container tightly closed and indicates that the unit-dose package is not child-resistant. Pharmacists are instructed to dispense a Medication Guide to each patient. The product is manufactured by Aurobindo Pharma USA and the code provided is TS/DRUGS2212008.*
Chemical Structure (Esomeprazole Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
